Gain Therapeutics (GANX) EPS (Basic) (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly EPS (Basic) of -$0.13 for Q1 2026, up 15.9% year-over-year from -$0.11 in Q1 2025, and down 1262.89% quarter-over-quarter from $0.01 in Q4 2025.
Gain Therapeutics (GANX) EPS (Basic) (2020 - 2026) Analysis & Trends
Gain Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.13 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 15.9% year-over-year to -$0.13; the TTM figure through Mar 2026 stood at -$0.39 (up 47.01% YoY), while the FY2025 annual figure was -$0.46, up 48.97% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.13, down from $0.01 in the prior quarter.
- The five-year high for EPS (Basic) was $1.07 in Q4 2022, with the low at -$0.62 in Q2 2023.
- The 5-year median for EPS (Basic) is -$0.22 (2024), against an average of -$0.2.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) jumped 436.53% in 2022, then sank 136.15% in 2023.
- Gain Therapeutics' EPS (Basic) stood at $1.07 in 2022, then sank by 136.15% to -$0.39 in 2023, then soared by 57.26% to -$0.16 in 2024, then jumped by 106.93% to $0.01 in 2025, then plunged by 1262.89% to -$0.13 in 2026.
- Business Quant data shows GANX's EPS (Basic) at -$0.13 in Q1 2026, $0.01 in Q4 2025, and -$0.15 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Gain Therapeutics | 85.12 Mn | 85.12 Mn | - | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | -0.15 |
| Jun 30, 2025 | -0.19 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.39 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.62 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | 1.07 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.43 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.32 |
| Sep 30, 2021 | -0.39 |